Latest Vivo Capital, LLC Stock Portfolio

Vivo Capital, LLC Performance:

2024 Q4: -7.53%YTD: 14.34%2023: 20.9%

Performance for 2024 Q4 is -7.53%, and YTD is 14.34%, and 2023 is 20.9%.

About Vivo Capital, LLC and 13F Hedge Fund Stock Holdings

Vivo Capital, LLC is a hedge fund based in PALO ALTO, CA. On 28-Apr-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $5.4 Billions. In it's latest 13F Holdings report, Vivo Capital, LLC reported an equity portfolio of $892.6 Millions as of 31 Dec, 2024.

The top stock holdings of Vivo Capital, LLC are SLNO, VRNA, GERN. The fund has invested 31.7% of it's portfolio in SOLENO THERAPEUTICS INC and 11.9% of portfolio in VERONA PHARMA PLC.

The fund managers got completely rid off HARMONY BIOSCIENCES HOLDINGS INC (HRMY), SINOVAC BIOTECH LTD. (SVA) and ALX ONCOLOGY HOLDINGS INC (ALXO) stocks. They significantly reduced their stock positions in VIRIDIAN THERAPEUTICS INC (VRDN), VERONA PHARMA PLC (VRNA) and INSTIL BIO INC (TIL). Vivo Capital, LLC opened new stock positions in ACLARIS THERAPEUTICS, INC. (ACRS), CIDARA THERAPEUTICS, INC. (CDTX) and BRIGHT MINDS BIOSCIENCES INC. The fund showed a lot of confidence in some stocks as they added substantially to UNICYCIVE THERAPEUTICS (UNCY), TREVI THERAPEUTICS INC (TRVI) and DELCATH SYSTEMS, INC. (DCTH).

Vivo Capital, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Vivo Capital, LLC made a return of -7.53% in the last quarter. In trailing 12 months, it's portfolio return was 14.34%.

New Buys

Ticker	$ Bought
aclaris therapeutics, inc.	22,044,400
cidara therapeutics, inc.	18,025,700
bright minds biosciences inc	9,061,620
dbv technologies sa	98,942

New stocks bought by Vivo Capital, LLC

Additions

Ticker	% Inc.
unicycive therapeutics	123
trevi therapeutics inc	116
delcath systems, inc.	71.37
corvus pharmaceuticals holdings	49.24

Additions to existing portfolio by Vivo Capital, LLC

Reductions

Ticker	% Reduced
viridian therapeutics inc	-41.45
verona pharma plc	-35.66
instil bio inc	-6.22

Vivo Capital, LLC reduced stake in above stock

Sold off

Ticker	$ Sold
sinovac biotech ltd.	-76,346,000
alx oncology holdings inc	-7,342,830
harmony biosciences holdings inc	-104,250,000
dbv technologies sa	-948,106
adverum biotechnologies, inc.	-5,850,000
engene holdings inc.	-4,479,450
codexis, inc	-1,195,480

Vivo Capital, LLC got rid off the above stocks

Sector Distribution

Vivo Capital, LLC has about 92.5% of it's holdings in Healthcare sector.

Sector	%
Healthcare	92.5
Others	7.5

Market Cap. Distribution

Vivo Capital, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

Category	%
SMALL-CAP	46.4
MID-CAP	25.6
MICRO-CAP	18.6
UNALLOCATED	7.5
NANO-CAP	1.9

Stocks belong to which Index?

About 32.7% of the stocks held by Vivo Capital, LLC either belong to S&P 500 or RUSSELL 2000 index.

Index	%
Others	67.3
RUSSELL 2000	32.7

Top 5 Winners (%)		%
ALGS	aligos therapeutics inc	360.1 %
DBVT	dbv technologies sa	296.1 %
CDTX	cidara therapeutics, inc.	85.4 %
ALLK	allakos inc	85.2 %
TENX	tenax therapeutics inc	78.9 %

Top 5 Winners ($)		$
VRNA	verona pharma plc	52.7 M
CDTX	cidara therapeutics, inc.	8.3 M
ALGS	aligos therapeutics inc	4.4 M
DCTH	delcath systems, inc.	3.7 M
VSTM	verastem inc	3.4 M

Top 5 Losers (%)		%
TIL	instil bio inc	-70.8 %
DTIL	precision biosciences inc	-57.5 %
OLMA	olema pharmaceuticals inc	-51.2 %
CRBP	corbus pharmaceuticals holdings	-42.8 %
CMPS	compass pathway plc	-40.0 %

Top 5 Losers ($)		$
SLNO	soleno therapeutics inc	-34.9 M
TIL	instil bio inc	-29.8 M
GERN	geron corp	-27.2 M
TERN	terns pharmaceuticals inc	-19.3 M
DYN	dyne therapeutics inc	-13.8 M

Vivo Capital, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Vivo Capital, LLC

Vivo Capital, LLC has 40 stocks in it's portfolio. About 73.7% of the portfolio is in top 10 stocks. SLNO proved to be the most loss making stock for the portfolio. VRNA was the most profitable stock for Vivo Capital, LLC last quarter.

Last Reported on: 13 Feb, 2025

	Ticker	Namesorted descending	% Portfolio	Shares Held	$ Value	Type	% Change
	SLNO	soleno therapeutics inc	31.68	6,291,850	282,819,000	unchanged	0.00
Historical Trend of SOLENO THERAPEUTICS INC Position Held By Vivo Capital, LLC What % of Portfolio is SLNO?: Number of SLNO shares held: Change in No. of Shares Held:
	VRNA	verona pharma plc	11.88	2,283,980	106,068,000	reduced	-35.66

	GERN	geron corp	10.80	27,225,300	96,377,500	unchanged	0.00

	TERN	terns pharmaceuticals inc	4.28	6,895,750	38,202,400	unchanged	0.00

		avadel pharmaceuticals plc	3.16	2,684,110	28,210,000	unchanged	0.00

	DYN	dyne therapeutics inc	2.94	1,114,960	26,268,500	unchanged	0.00

	ACRS	aclaris therapeutics, inc.	2.47	8,888,890	22,044,400	new

	DCTH	delcath systems, inc.	2.31	1,708,580	20,571,300	added	71.37

	VRDN	viridian therapeutics inc	2.11	982,576	18,836,000	reduced	-41.45

	CDTX	cidara therapeutics, inc.	2.02	670,600	18,025,700	new

	ERAS	erasca inc	1.90	6,756,760	16,959,500	unchanged	0.00

	TRVI	trevi therapeutics inc	1.61	3,487,900	14,370,200	added	116

	ATXS	astria therapeutics inc	1.55	1,552,680	13,881,000	unchanged	0.00

	RZLT	rezolute inc	1.54	2,797,700	13,708,800	unchanged	0.00

	SERA	sera prognostics inc	1.50	1,650,440	13,434,600	unchanged	0.00

		tourmaline bio inc.	1.34	591,882	12,003,400	unchanged	0.00

	CRVS	corvus pharmaceuticals holdings	1.34	2,234,570	11,954,900	added	49.24

	TIL	instil bio inc	1.25	585,485	11,176,900	reduced	-6.22

	ORIC	oric pharmaceuticals inc	1.16	1,277,820	10,312,000	unchanged	0.00

	ABEO	abeona therapeutics, inc.	1.15	1,842,750	10,264,100	unchanged	0.00